return to news
  1. Sanofi India, Tata Motors, IREDA, Coal India, IndiGo: Check top buzzing stocks of the day

Market News

Sanofi India, Tata Motors, IREDA, Coal India, IndiGo: Check top buzzing stocks of the day

Ahana Chatterjee - image.jpg

5 min read | Updated on February 28, 2025, 12:42 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Shares of Sanofi India, the Indian arm of the French multinational pharmaceutical and healthcare company, Sanofi S.A., surged as much as 6.42% to ₹5,317.75 apiece on the BSE on Friday amid a rout in stock markets across the globe, including India

Shares of Coal India rose as much as 3.2% to ₹375.75 apiece on the NSE on Friday, February 28. | Image: Shutterstock

Shares of Coal India rose as much as 3.2% to ₹375.75 apiece on the NSE on Friday, February 28. | Image: Shutterstock

The equity benchmark indices crashed over 1% on Friday, February 28, after staging a gap down opening, mirroring losses in global markets.

At 12:27 PM, the S&P BSE SENSEX was trading at 73,635.68, tumbling 976.75 points, or 1.31%, while the NSE's NIFTY50 index was at 22,246.20, declining 298.85 points, or 1.33%.

Here is a list of stocks that are buzzing in today's trade.
Premier Energies: Shares of Premier Energies, a leading solar cell and module manufacturer, dropped as much as 9% to ₹840.15 apiece on the NSE on Friday, February 28, as the company's six-month shareholding lock-in period ends today.

However, the stock recovered later, and when last seen, it was trading 4% lower at ₹887.60.

According to news reports, which quoted Nuvama Alternative and Quantitative Research, as many as 10.6 crore shares of the company will become eligible to trade today as the lock-in period ends. The number of shares mentioned amounts to 23% of the company's outstanding equity.

KSB: Shares of industrial valve manufacturer KSB rose over 8% on Friday after the company released its financial results for the quarter ended December 2024. The company follows a January to December calendar year.

The stock climbed as much as 8.12% to ₹658 apiece on the National Stock Exchange. At 9:39 am, it was up 6.87% to ₹650.35 per unit.

KSB reported a 33.15% increase in its consolidated net profit to ₹73.1 crore in the fourth quarter of the calendar year 2024 (Q4 CY24). In the year-ago period, the post-tax profit was ₹54.9 crore. Revenue from operations advanced 20.5% to ₹726.4 crore in Q4 CY24, compared to ₹602.6 crore in the year-ago quarter.

Transrail Lighting: Shares of Transrail Lighting, the recently listed company, surged as much as 6% to ₹517.70 apiece in the opening deals on the NSE on Friday, February 28, as the EPC company, on Thursday, said it has secured an order worth ₹2,752 crore in the power transmission and distribution (T&D) sector.

However, minutes later, the stock pared gains. Last seen, the stock was trading 2.51% higher at ₹500.30 apiece on the NSE.

With the latest win, its order book has touched the level of ₹7,400 crore, the company said in a statement.

Tata Motors: Shares of Tata Motors continued to bleed on Friday, February 28, amid broad-based selling.

At 10:52 AM, the auto major tumbled 2.8% to ₹630.40 on the National Stock Exchange (NSE). Shares of the firm had touched its 52-week low of ₹630 per share during the intraday trade.

Market investors remained worried about Tata Motors after its subsidiary Jaguar Land Rover maker (JLR) witnessed a fall in margins in the October-December quarter. Further, the demand outlook in key markets like China and Europe remained weak. This was the main reason for Tata Motors’ poor performance in Q3 FY25. Read more
Sanofi India: Shares of Sanofi India, the Indian arm of the French multinational pharmaceutical and healthcare company, Sanofi S.A., surged as much as 6.42% to ₹5,317.75 apiece on the BSE on Friday, February 28, amid a rout in stock markets across the globe, including India.
The stock witnessed heavy demand as the company posted a good set of numbers for the December quarter (Q4 FY25). Sanofi India reported a consolidated net profit of ₹91.3 crore for the quarter ending December 31, 2024 (Q4 FY25). The figure was down 33.6% as compared to the ₹137.7 crore profit logged in the corresponding quarter of the previous fiscal year. Revenue from operations came in at ₹514.9, up 9.7% against ₹469.2 crore registered in the year-ago period. Read more
Granules India: Shares of pharmaceuticals major Granules India declined nearly 8% on Friday after the United States Food and Drug Administration (US FDA) issued a warning letter to the company's Gagillapur facility.

Intraday, the stock fell as much as 7.65% to ₹468.15 per share on the National Stock Exchange (NSE). At 11:02 am, it was down 6.83% to ₹472.30 apiece.

On Wednesday, the US FDA issued a warning letter to the pharma company's Gagillapur facility. Read more
Coal India: Shares of Coal India rose as much as 3.2% to ₹375.75 apiece on the NSE on Friday, February 28, as Northern Coalfields (NCL), a subsidiary of Coal India, will impose a "Singrauli Punarasthapan (rejuvenation) Charge" of ₹300 per tonne on coal dispatches across all its mines from May 1, 2025.
The additional charge is expected to generate around ₹3,877.50 crore, NCL said in a regulatory filing. Read more
IndiGo: Shares of the country's largest airline operator, Interglobe Aviation, rose as much as 1.78% to hit an intraday high of ₹4,520 in an otherwise weak market after it further cemented its dominance in Indian skies. The company's market share in the aviation market expanded to 65.2% in January from 64.4% in the previous month.
IndiGo also recorded the highest On Time Performance (OTP) at 75.5%, while that of Akasa Air stood at 71.5% in January, data from the Directorate General of Civil Aviation showed. Meanwhile, domestic air traffic grew 11.28% to 14.6 million in January compared to the year-ago period, according to official data. Read more
IREDA: State-owned Indian Renewable Energy Development Agency Limited (IREDA) shares plunged over 7% on Friday after the firm entered the Futures & Options (F&O) segment for the March series.

During the intraday trade, IREDA shares were trading 7.62% lower at ₹153.82 per share on NSE.

This week IREDA also got shareholders' approval for raising up to ₹5,000 crore through issuance of equity shares to qualified institutional buyers.

Biocon: Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

The GLP-1 peptide, Liraglutide, will be marketed in the UK under the brand names Liraglutide Biocon for diabetes and Biolide for chronic weight management, the company said in a statement.

However, during the intraday trade, shares of Biocon were trading at ₹300.3 per share, tanking 3.70% on NSE.

Upstox

About The Author

Ahana Chatterjee - image.jpg
Ahana Chatterjee is a business journalist with 7 years of experience across several leading news platforms. At Upstox, she covers stock markets and corporate news.

Next Story